Status:
COMPLETED
Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Ulcerative Colitis
Primary Sclerosing Cholangitis
Eligibility:
All Genders
10-90 years
Brief Summary
Primary sclerosing cholangitis (PSC) occurs in approximately 10 % of patients with ulcerative colitis (UC), but the outcome of reconstructive surgery is not clear. The purpose of this study was to det...
Detailed Description
Primary sclerosing cholangitis (PSC) is characterised by inflammation and fibrosis of the biliary tree and the condition can lead to end-stage liver disease. PSC is strongly associated with inflammato...
Eligibility Criteria
Inclusion
- UC
- PSC
- IPAA
- IRA
Exclusion
- non-UC
- non-PSC
- no consent
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT01798953
Start Date
January 1 2010
End Date
November 1 2013
Last Update
April 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Inst for Clinical Sciences, Sahlgrenska University Hospital
Gothenburg, Göteborg, Sweden, 41685